Skip to main content
. Author manuscript; available in PMC: 2023 Aug 5.
Published in final edited form as: Obstet Gynecol. 2021 Jul 1;138(1):21–31. doi: 10.1097/AOG.0000000000004424

Table 4.

Univariate and Multivariate Logistic Regression of Predictors of Adherence to National Comprehensive Cancer Network Treatment Guidelines Among Patients With Endometrial Carcinoma Between 2006 and 2015 in the SEER (Surveillance, Epidemiology, and End Results) Database (N=83,883)

Model 1
Model 2
Model 3
Characteristic Unadjusted OR (95% CI) Adjusted OR (95% CI)

Race-ethnicity
 White Referent Referent
 Black 0.88 (0.83–0.92)* 0.89 (0.84–0.94)*
 Latina 0.79 (0.75–0.82)* 0.92 (0.88–0.96)*
 Asian 1.08 (1.03–1.15) 1.14 (1.08–1.21)*
 Native Hawaiian or Pacific Islander 1.01 (0.89–1.15) 1.19 (1.04–1.35)
 American Indian or Alaska Native 0.73 (0.62–0.87)* 0.82 (0.69–0.98)
Neighborhood SES
 Highest Referent Referent
 High-middle 0.89 (0.85–0.93)* 0.89 (0.86–0.93)*
 Middle 0.83 (0.80–0.87)* 0.84 (0.80–0.88)*
 Low-middle 0.80 (0.77–0.83)* 0.82 (0.78–0.86)*
 Lowest 0.73 (0.70–0.76)* 0.73 (0.69–0.77)*
Age at diagnosis (y)
 Younger than 54 Referent
 54–61 1.37 (1.32–1.43)*
 62–68 1.54 (1.47–1.61)*
 69 or older 1.33 (1.27–1.38)*
Stage at diagnosis
 I Referent
 II 2.06 (1.93–2.21)*
 III 2.14 (2.04–2.26)*
 IV 0.31 (0.29–0.33)*
Histology
 Endometroid carcinomas Referent
 Other carcinomas 0.56 (0.54–0.58)*
Grade
 1, well differentiated Referent
 2, moderately differentiated 2.58 (2.48–2.68)*
 3, poorly differentiated 3.45 (3.28–3.64)*
 4, undifferentiated; anaplastic 3.25 (3.00–3.53)*
 Unknown 1.48 (1.42–1.54)*
Year of diagnosis 0.99 (0.98–0.99)*

SES, socioeconomic status.

Model 1 includes only race and ethnicity, model 2 includes only neighborhood SES, and model 3 includes race and ethnicity, neighborhood SES, and all demographic and clinical covariates (age at diagnosis, stage at diagnosis, histology, grade, and year of diagnosis).

*

P<.001.

P< .05.